Skip to content

Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy

Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy: a Pilot Study

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02987985
Enrollment
50
Registered
2016-12-09
Start date
2017-10-15
Completion date
2020-12-20
Last updated
2021-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesics, Analgesics, Opioid, Anesthesia, Dexmedetomidine, Gabapentin, General Anesthesia, Ketamine, Lidocaine, Narcotics, Obstructive Sleep Apnea of Child, Pathologic Processes, Physiologic Effects of Drugs, Postoperative Complications, Pulse Oximetry, Respiratory Depression, Sleep Disordered Breathing, Tonsillectomy

Keywords

Opioid-sparing, Opioid-free

Brief summary

The objective of this trial is to determine whether an opioid-free general anesthetic (OFA) technique utilizing ketamine, dexmedetomidine, lidocaine, and gabapentin can help reduce postoperative respiratory depression in the post-anesthesia care unit and ward in children with sleep-disordered breathing undergoing tonsillectomy when compared with traditional opioid-containing techniques. It is expected that this OFA regimen will have a measurable reduction on postoperative respiratory depression in children with sleep-disordered breathing.

Detailed description

The objective of this trial is to determine whether an opioid-free general anesthetic can help reduce postoperative respiratory depression in the post-anesthesia care unit and ward in children with sleep-disordered breathing undergoing tonsillectomy when compared with traditional opioid-containing techniques.

Interventions

acetaminophen 15 mg/kg, gabapentin 10 mg/kg

DRUGAcetaminophen

acetaminophen 15 mg/kg

DRUGKetamine , Lidocaine , Dexmedetomidine

Ketamine 0.5 mg/kg, Lidocaine 1 mg/kg, Dexmedetomidine 0.3 mcg/kg

DRUGFentanyl, Dexmedetomidine

Fentanyl 0.5 mcg/kg, Dexmedetomidine 0.3 mcg/kg

DRUGDexamethasone , Ondansetron

Dexamethasone 150 mcg/kg, Ondansetron 50 mg/kg

DRUGSevoflurane

Sevoflurane (dose titrated to effect)

DRUGSevoflurane, Fentanyl

Sevoflurane (dose titrated to effect), Fentanyl as needed (dose at anesthesiologist's discretion)

Sponsors

University of Saskatchewan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 12 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 0-12 years with Sleep Disordered Breathing (SDB) who are scheduled for elective Tonsillectomy/AdenoTonsillectomy (T/AT) will be recruited at Royal University Hospital, Saskatoon, Saskatchewan.

Exclusion criteria

* age \> 12; American Society of Anesthesiologists (ASA) Classification \> IV; significant cardiorespiratory, neurological, craniofacial, hepatic, renal, or genetic disorders, excluding SDB; concomitant surgical procedures other than myringotomy and tubes; and allergy to any of the study drugs

Design outcomes

Primary

MeasureTime frameDescription
Respiratory depression24 hours following surgeryNumber of desaturation events (oxygen saturation by pulse oximetry (SPO2) \<90%) as measured by a Masimo Radical-7 pulse oximeter during the first postoperative night's sleep

Secondary

MeasureTime frameDescription
Quantified opioid consumption24 hours following surgeryQuantified opioid consumption
Pediatric Agitation Emergence Delirium (PAED) scale24 hours following surgeryPediatric Agitation Emergence Delirium (PAED) scale
Face Legs Activity Cry Consolability (FLACC) scale24 hours following surgeryFace Legs Activity Cry Consolability (FLACC) scale
Time until Post Anesthesia Care Unit (PACU) discharge readiness24 hours following surgeryTime until Post Anesthesia Care Unit (PACU) discharge readiness
Other adverse effects24 hours following surgeryOther adverse effects

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026